Net shares · 90d
-5.7M
1.3M buy · 7.0M sell
Net value · 90d
-$219.6M
$23.0M in · $242.6M out
Sentiment · 90d
Net selling
9% buying · 91% selling
Open-market trades · 90d
3
1.3M buy · 7.0M sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 90d
-
JBIO Grant·A
Director, 10% Owner
$0
34.8K sh
Own New
-
APGE Grant·A
Director
$0
7.7K sh
Own New
-
ORKA Grant·A
Director, 10% Owner
$0
9.1K sh
Own New
-
CBIO Grant·A
Director, 10% Owner
$0
11.1K sh
Own New
-
SYRE Grant·A
Director
$0
8.0K sh
Own New
-
VRDN Buy·P
Director, 10% Owner
$20.0M
1.2M sh · $17.00
Own +30%
-
ZBIO Buy·P
Director
$3.0M
150.0K sh · $20.00
Own +7%
-
COGT Exercise·C
Director
$0
28.0K sh
Own +245%
-
COGT Sell·S
Director
$242.6M
7.0M sh · $34.66
Own -56%
-
COGT Exercise·C
Director
—
7.0M sh
Own +127%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | JBIO | Grant A | 34.8K | $0 |
| Jun 9, 2026 | APGE | Grant A | 7.7K | $0 |
| Jun 2, 2026 | ORKA | Grant A | 9.1K | $0 |
| Jun 2, 2026 | CBIO | Grant A | 11.1K | $0 |
| May 27, 2026 | SYRE | Grant A | 8.0K | $0 |
| May 11, 2026 | VRDN | Buy P | 1.2M | $20.0M |
| Mar 31, 2026 | ZBIO | Buy P | 150.0K | $3.0M |
| Mar 31, 2026 | COGT | Exercise C | 28.0K | $0 |
| Mar 31, 2026 | COGT | Sell S | 7.0M | $242.6M |
| Mar 31, 2026 | COGT | Exercise C | 7.0M | — |
Buy Sell Non-market (grant · exercise · gift)
About Fairmount Funds Management LLC
This profile aggregates every SEC Form 4 insider transaction reported by Fairmount Funds Management LLC across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.